BRCA (breast cancer, early onset) encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and a previous study has reported that after a diagnosis of, women breast cancer with a BRCA1 or BRCA2 mutation face a twofold increase in the risk of diabetes (Bordeleau et al. 2011). The gene discussed is BRCA2; the disease is diabetes mellitus.